β-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 3, 2009, Pages 519-529

  Luchowska, Elzbieta ^a   Kloc, Renata ^a   Olajossy, Bartosz ^a   Wnuk, Sebastian ^a   Wielosz, Marian ^a   Owe Larsson, Bjorn ^b   Urbanska, Ewa M ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Glial culture; Kynurenic acid; Kynurenine aminotransferase; Neuroprotein; Protein kinase A

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; 8 BROMO CYCLIC AMP; ADRENALIN; BETAXOLOL; BUNGAROTOXIN RECEPTOR; CLENBUTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DENOPAMINE; FORMOTEROL; KT 5720; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROPRANOLOL; SALBUTAMOL; SODIUM CHLORIDE; TIMOLOL; XAMOTEROL;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GLIA CELL; MALE; MIXED CELL CULTURE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; WISTAR RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADRENERGIC AGENTS; ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN CHEMISTRY; CARBAZOLES; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLIAL FIBRILLARY ACIDIC PROTEIN; KYNURENIC ACID; L-LACTATE DEHYDROGENASE; MALE; NEUROGLIA; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; THIONUCLEOTIDES; TRANSAMINASES;

EID: 62849116641     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.02.002     Document Type: Article

References (38)

1. Adolph O., Köster S., Räth M., Georgieff M., Weigt H.U., Engele J., et al. Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway. Glia 55 (2007) 1699-1707
2. Arnsten A.F., Ramos B.P., Birnbaum S.G., and Taylor J.R. Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol Med 11 (2005) 121-128
3. Carpenedo R., Pittaluga A., Cozzi A., Attucci S., Galli A., and Raiteri M. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 13 (2001) 2141-2147
4. Chmiel-Perzyńska I., Perzyński A., Wielosz M., and Urbańska E.M. Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and d,l-homocysteine on the brain production of kynurenic acid. Pharmacol Rep 59 (2007) 268-273
5. Culmsee C., Stumm R.K., Schafer M.K., Weihe E., and Krieglstein J. Clenbuterol induces growth factor mRNA, activates astrocytes, and protects rat brain tissue against ischemic damage. Eur J Pharmacol 379 (1999) 33-45
6. Do K.Q., Benz B., Sorg O., Pellerin L., and Magistretti P.J. Beta-Adrenergic stimulation promotes homocysteic acid release from astrocyte cultures: evidence for a role of astrocytes in the modulation of synaptic transmission. J Neurochem 68 (1997) 2386-2394
7. Eid T., Du F., and Schwarcz R. Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region. Neuroscience 68 (1995) 645-656
8. Erhardt S., Schwieler L., Nilsson L., Linderholm K., and Engberg G. The kynurenic acid hypothesis of schizophrenia. Physiol Behav 92 (2007) 203-209
9. Feinstein D.L., and Rozelman E. Norepinephrine suppresses l-arginine uptake in rat glial cells. Neurosci Lett 223 (1997) 37-40
10. Guidetti P., Okuno E., and Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50 (1997) 457-465
11. Guidetti P., Amori L., Sapko M.T., Okuno E., and Schwarcz R. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem 102 (2007) 103-111
12. Hertz L., Chen Y., Gibbs M.E., Zang P., and Peng L. Astrocytic adrenoceptors: a major drug target in neurological and psychiatric disorders?. Curr Drug Targets CNS Neurol Disord 3 (2004) 239-267
13. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21 (2001) 7463-7473
14. Huneycutt B.S., and Benveniste E.N. Regulation of astrocyte cell biology by the cAMP/protein kinase A signaling pathway. Adv Neuroimmunol 5 (1995) 261-269
15. Junker V., Becker A., Hühne R., Zembatov M., Ravati A., Culmsee C., et al. Stimulation of β-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 446 (2002) 25-36
16. Kloc R., Luchowska E., Wielosz M., Owe-Larsson B., and Urbanska E.M. Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism. Neurosci Lett 435 (2008) 169-173
17. Kocki T., Luchowski P., Luchowska E., Wielosz M., Turski W.A., and Urbańska E.M. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Neurosci Lett 346 (2003) 97-100
18. Kocki T., Wielosz M., Turski W.A., and Urbanska E.M. Enhancement of brain KYNA production by anticonvulsants-novel mechanism of antiepileptic activity?. Eur J Pharmacol 41 (2006) 147-151
19. 3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther 305 (2003) 653-659
20. Luccini E., Musante V., Neri E., Raiteri M., and Pittaluga A. N-methyl-d-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. J Neurosci Res 85 (2007) 3657-3665
21. Luchowski P., Luchowska E., Turski W.A., and Urbanska E.M. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Neurosci Lett 330 (2002) 49-52
22. Luchowska E., Luchowski P., Paczek R., Ziembowicz A., Kocki T., Turski W.A., et al. Dual effect of dl-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. J Neurosci Res 79 (2005) 375-382
23. Luchowska E., Kloc R., Wnuk S., Olajossy B., Wielosz M., and Urbańska E.M. Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures. Pharmacol Rep 60 (2008) 574-577
24. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., and Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol 47 (1993) 73-81
25. Mantyh P.W., Rogers S.D., Allen C.J., Catton M.D., Ghilardi J.R., and Levin L.A. Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J Neurosci 15 (1995) 152-164
26. Marien M.R., Colpaert F.C., and Rosenquist A.C. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev 45 (2004) 38-78
27. Miura H., Ozaki N., Sawada M., Isobe K., Ohta T., and Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11 (2008) 198-209
28. Miüller N., and Schwarz M.J. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm Suppl 72 (2007) 269-280
29. Myint A.M., Kim Y.K., Verkerk R., Scharpé S., Steinbusch H., and Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98 (2007) 143-151
30. Németh H., Toldi J., and Vecsei L. Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res 2 (2005) 249-260
31. Németh H., Toldi J., and Vécsei L. Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies. J Neural Transm Suppl 70 (2006) 285-304
32. Prescott C., Weeks A.M., Staley K.J., and Partin K.M. Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402 (2006) 108-112
33. Rassoulpour A., Wu H.Q., Ferre S., and Schwarcz R. Nanomolar concentrations of KYNA reduce extracellular dopamine levels in the striatum. J Neurochem 93 (2005) 762-765
34. Turski W.A., Dziki M., Urbanska E., Calderazzo-Filho L.S., and Cavalheiro E.A. Seizures induced by aminooxyacetic acid in mice: pharmacological characteristics. Synapse 7 (1991) 173-180
35. Urbanska E., Ikonomidou C., Sieklucka M., and Turski W.A. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum. Synapse 9 (1991) 129-135
36. Urbanska E.M., Kocki T., Saran T., Kleinrok Z., and Turski W.A. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. NeuroReport 8 (1997) 3501-3505
37. Weber B., Steinfath M., Scholz J., and Bein B. Neuroprotective effects of alpha2-adrenergic receptor agonists. Drug News Perspect 20 (2007) 149-154
38. Zhu Y., Culmsee C., Roth-Eichhorn S., and Krieglstein J. Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience 107 (2001) 593-602